Correlation Between Apogee Therapeutics, and BioNTech

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and BioNTech SE, you can compare the effects of market volatilities on Apogee Therapeutics, and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and BioNTech.

Diversification Opportunities for Apogee Therapeutics, and BioNTech

0.04

Correlation Coefficient

Apogee Therapeutics,  BioNTech

Significant diversification

The 3 months correlation between Apogee and BioNTech is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and BioNTech go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and BioNTech

Given the investment horizon of 90 days Apogee Therapeutics, is expected to generate 1.18 times less return on investment than BioNTech. In addition to that, Apogee Therapeutics, is 1.26 times more volatile than BioNTech SE. It trades about 0.06 of its total potential returns per unit of risk. BioNTech SE is currently generating about 0.1 per unit of volatility. If you would invest  8,252  in BioNTech SE on September 24, 2024 and sell it today you would earn a total of  3,056  from holding BioNTech SE or generate 37.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	99.21%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  BioNTech SE

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

BioNTech SE

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Apogee Therapeutics, and BioNTech

The main advantage of trading using opposite Apogee Therapeutics, and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Apogee Therapeutics, Common and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .